Latest news with #Korean
TimesLIVE
16 minutes ago
- Sport
- TimesLIVE
Bayanda Walaza claims Universiade sprint double; last-gasp gold for Smith
Bayanda Walaza claimed the sprint double at the World Student Games in Germany on Thursday as he lifted the 200m crown to add to the 100m title he won earlier in the week. His performance concluded a dramatic night of track and field for South Africa where Aiden Smith snatched the shot-put gold with his final throw of the competition. Walaza, the double sprint king from the 2024 under-20 world championships in Peru, exploded out the blocks with his trademark lightning start and he worked that advantage through the bend into the home straight where he kept his lead to cross the line in 20.63sec, seven-hundredths of a second in front of Spaniard Adria Medero. It was 12 years since Anaso Jobodwana won South Africa's first Universiade sprint double. In the men's shot put, left-handed Smith was languishing well outside the top three with a best throw of 19.23 when he stepped into the circle for his final throw of the night, finding more than an extra metre to claim first place at the death. The mixed 4x400m relay team of Mthi Mthimkulu, Precious Molepo, men's 400m champion Lythe Pillay and Marlie Viljoen won silver ahead of the US, clocking 3min 16.42sec as they ended behind Poland. And Mondray Barnard bagged third place in the men's 110m hurdles in 13.59sec to miss silver by a few thousandths of a second. Earlier, Walaza won his 200m semifinal in 20.76, just one hundredth of a second in front of Medero. It was the second fastest time of the semifinals, with Korean Lee placing first in his heat in 20.73. But it was the South African who found the right gears in the final. Colette Uys, bronze medallist in the women's shot put, ended sixth in the women's discus with a best release of 57.50m. Charné Swart-Du Plessis was sixth in the women's 800m. In the women's 400m hurdles, Hannah van Niekerk was unable to keep up with the leaders of a fast race, slipping back to seventh in 58.02. Even the 56.16 personal best she set earlier in the competition would have earned her only fifth spot. Karmen Fouche ended eighth in the women's hepthathlon, matching the position her mother Maralize Visser achieved at the 1997 edition of this showpiece in Sicily, with fewer than 20 points separating them. Fouche amassed 5,783 and Visser 5,765. Gabriella Marais, who won the women's 100m bronze, was unable to progress beyond the semifinals of the women's 200m. South Africa was lying seventh on the medals table with 16 medals, comprising six gold, three silver and seven bronze.
Vogue
43 minutes ago
- Health
- Vogue
The Best Korean Toner Pads Brighten and Smooth in a Single Swipe
We get it: You're hesitant about adding another step to your already-stacked skin-care routine, but if it's glass skin you're after, you're well-suited for Korean toner pads. For the uninitiated, 'toners serve as both a treatment and a way to prep your skin for further products in your multistep skin-care routine,' founder of Soko Glam, Charlotte Cho previously told Vogue. Vogue's Favorite Korean Toner Pads An easily misunderstood step, per Cho, the benefit of opting for a toner pad format is its sheer convenience. While liquid formulas require a separate cotton round (often absorbing more product than your skin does), toner pads come pre-soaked and ready to use—no extra tools required. Housed in sleek jars, often with their own mini tweezers for hygienic retrieval, these pads deliver the perfect dose of product with every swipe. From excess oil and irritation to dull skin and anti-aging, Korean toner pads reflect K-beauty's signature balance of skin-first tradition and cutting-edge innovation. Whether you're after a quick refresh post-cleansing or a targeted 15-minute masking moment (yes, some formulas can double as mini sheet masks), toner pads offer a tailored approach to treating skin. Below, a look at eight formulas to consider, recommended by Vogue editors and the pros. In This Story Best for Blackheads: Medicube Zero Pore Pads
Axios
4 hours ago
- Business
- Axios
PR firms unite to help small businesses bounce back from natural disasters
Communication professionals are leveraging their expertise to help raise awareness for businesses in need or those impacted by natural disasters. Driving the news: Following the recent wildfires in Los Angeles, several communication and PR firms united to form the LA Strong Comms Coalition to support small businesses that had been affected. The 40-member coalition is made up of freelancers, boutique agencies like JSA+Partners, Karsha Chang Public Relations and Hustle & Co, and big firms like Zeno Group and Weber Shandwick. Zoom in: LASCC has secured over 30 media stories for its pro bono clients in the past six months, helping businesses recover. For example, This Girl Walks Into A Bar secured a feature on the " Today" show in May, and within 20 minutes of airing, sales driven by the story paid for two months of warehouse fees, says owner Jordan Catapano. A local TV segment led to a significant uptick in online sales and in-store foot traffic for PlayLab Beauty, which lost its office and inventory of Korean and Japanese beauty supplies in the Eaton Fire. Zoom out: Many community PR chapters provide pro bono support to charities or nonprofits in their regions. For example, every two years, Washington Women in Public Relations picks a nonprofit organization to provide with free communications and PR support. This year, it has partnered with Running Start, a nonpartisan organization for young women running for political office. What they're saying: "As a society, the news cycle moves quickly but many small businesses are left with nothing and need to pick up the pieces after the cameras leave," Jennifer Stephens Acree, founder and CEO JSA+Partners, told Axios.
Time Out
5 hours ago
- Entertainment
- Time Out
The summer edition of Dine LA is finally back—and here are our favorite deals
Beginning tomorrow, Dine LA is back. Now in its 17th year, L.A.'s biggest restaurant week offers prix-fixe menus starting from $15 per person, though many places now opt to offer menus in the priciest, wide-ranging category: $65 and above. For the next two weeks, Angelenos can score a handful of small discounts at restaurants across the city, including a few of what I consider the city's best restaurants. For those who were going to splurge anyway, you can even score a two-Michelin-star meal at a $75 discount over at Mélisse in Santa Monica. For all of those hunting for an actual bargain, I've found 17 different places across Los Angeles that I'd consider a good deal, in one way or another. My personal favorites include the pair of $25 and $35 meal deals from Koreatown's Soban, home to L.A.'s best soy-marinated crab and one of the best banchan selections in the city. (Any genuine lover of Korean cuisine knows that the complimentary side dishes provided with your meal are one of the best representations of a given restaurant's true culinary capabilities.) Did I mention Soban is also one of the city's best restaurants? Another truly great option is the $65 prix-fixe menu from the Girl & the Goat in the Arts District, which includes five family-style dishes and a matcha tres leches with rhubarb-strawberry sorbet for dessert. While Top Chef alum Stephanie Izard's globally inspired small plates restaurant often gets overlooked with all the other amazing options in the destination restaurant-heavy neighborhood, the Dine LA menu might just remind you why this brick-lined, plant-filled restaurant is a great option to keep in your back pocket for your next night out in greater Downtown L.A. Until Somni reopened last November and upstaged all other restaurants in West Hollywood (it also recently got three Michelin stars!), Ardor was my top dining pick in the city-neighborhood, and it's also participating in Dine LA. The swanky hotel restaurant inside the West Hollywood EDITION offers a vegetable-forward menu within its cinematic dining room and verdant outdoor patio. The $65 prix-fixe menu nets you the eatery's signature tomato-topped milk bread, plus your choice of Spanish octopus or tandoor carrots as an appetizer. For mains, choose between skirt steak, king crab tagliatelle or Ardor's standout sweet potato curry. While I've yet to personally try the chocolate espresso torte on Ardor's Dine LA menu, I've loved every dessert I've tried at the restaurant, so it's likely a safe bet as well. Finally, I'd like to recommend bookmarking two restaurants that have yet to release their Dine LA menus: Mr. T in Hollywood and Sushi Kisen in Arcadia. Both restaurants will be offering menus in the $65 and over category. Mr. T offers République alum Alisa Vannah's rendition of modern Parisian cuisine. Co-owned by music mogul Jay-Z (whose offices are located upstairs), it's one of the best French restaurants in the city, with a gorgeous patio full of string lights and a fire pit. As for Sushi Kisen, the San Gabriel Valley sushi restaurant is one of my favorite places for sushi in L.A. County. Even on a regular day, the omakase at the counter is a relative bargain. Despite the fact it takes over an hour for me to drive there in normal traffic, I spent my birthday weekend shlepping to Arcadia for the restaurant's second anniversary kaisendon, which came topped with blue crab, ikura, sea urchin and shrimp. The set also came with a side of marinated sashimi. While Sushi Kisen has yet to publish its Dine LA menu, you can rest assured that whatever they're offering will be a steal in terms of fish quality and overall value. While it's true that the vast majority of Dine LA prix-fixe menus aren't really deals anymore, these handful of options will be more than enough to keep you happy during the summer edition. Bon appétit!
UPI
5 hours ago
- Business
- UPI
South Korea's Samsung Biologics, Celltrion log stellar performances
1 of 2 | South Korean biopharmaceutical contract manufacturer Samsung Biologics posted a stellar performance in the first half of this year. Photo courtesy of Samsung Biologics SEOUL, July 24 (UPI) -- The South Korean economy struggles as the country's gross domestic product growth rate is feared to more than halve to less than 1% this year, compared to 2% for 2024. However, its defense and shipbuilding industries are faring well. Also among the high achievers are biopharmaceutical contract manufacturers, including Samsung Biologics and Celltrion. Samsung Biologics, one of the world's largest contract development and manufacturing organizations, or CDMOs, announced Wednesday that it posted record-high $1.88 billion in sales during the first six months of 2025, up 21.3% from a year earlier. Its operating profit amounted to $700 million, up 46.75%. The company also said that it has signed contracts worth $2.4 billion in the first half of the year, which is more than 60% of its total annual order volume for 2024. "As global demand for CDMO services continues to rise, we are rapidly expanding our production capacity," Samsung Biologics said in a statement. "Backed by our world-class CDMO capabilities, we plan to intensify our efforts to win more orders, particularly targeting the world's top 40 pharmaceutical companies." Samsung's local rival, Celltrion, is likewise seeing impressive results. The outfit announced Tuesday that its first-half turnover stood at $1.31 billion, up 11.9% year-on-year. Its operating income more than tripled to $285 million. The company's sales for this year are expected to top $3 billion for the first time, and its bottom line is projected to near the $1 billion mark. Observers have positive outlooks for the two powerhouses. "Samsung Biologics is beefing up its global competitiveness through the second campus, which includes plants five to eight," KB Securities researcher Kim Hye-min said in a market report. "The company is also expanding its capabilities beyond traditional monoclonal antibody-focused CDMO services to next-generation modalities and pre-filled syringes," she noted. Prefilled syringe manufacturing means that Samsung Biologics rolls out drugs in ready-to-inject formats. Global pharmaceutical clients tend to request this for chronic diseases or biologic treatments. Regarding Celltrion, Heungkuk Securities analyst Lee Ji-won said in a recent report that this year would be a pivotal point for the company's profit growth momentum. "Celltrion is predicted to demonstrate a significant year-on-year increase in profits, driven by the solid performance of newly launched high-margin biosimilars," Lee said. Experts said the CDMO businessm which is based on outsourced manufacturing, is an area in which Korean companies have advantages. "Although the Korean economy languishes due to various reasons this year, the biopharmaceutical outsourcing business is likely to rack up stellar performances for the time being. Samsung Biologics and Celltrion will spearhead the trend," Seoul-based business tracker Leaders Index CEO Park Ju-gun told UPI. "Samsung Biologics has already become an established player in the market, favored by global biopharmaceutical giants thanks to its cost competitiveness and quick delivery. Celltrion is also trying hard to become a big name in the market," he said. Economic analyst Kim Joon-Kyung, formerly vice chairman at Deloitte Consulting Korea, agreed. "First of all, the CDMO industry is promising. And from the perspective of Samsung, the business shares many characteristics with semiconductor production. Hence, the group had a good reason to tap into the CDMO sector," Kim said in a phone interview. "Celltrion did not have such advantages. But the company secured technological edges early on, which is quite an achievement. That's why Celltrion is showing solid performances now," he said. Samsung Electronics, the mother company of Samsung Biologics, is the world's largest maker of memory chips. According to U.S. market intelligence firm BCC Research, the global CDMO market is expected to expand to $191.6 billion by 2029 from $136.6 billion last year based on mounting demand for outsourced drug development and manufacturing. Other biopharmaceutical companies in Korea also are striving to tap into the lucrative CDMO business, including SK Bioscience and Lotte Biologics. Toward that end, SK Bioscience acquired a controlling stake in IDT Biologika of Germany, which is one of the top 10 global vaccine CDMOs, late last year. Lotte Biologics has launched operations of its antibody-drug conjugate facility at its Syracuse Bio Campus in the United States. The company also is preparing its first plant located just west of Seoul, aiming to begin commercial production in 2027.
